Literature DB >> 31997391

GAN and dual-input two-compartment model-based training of a neural network for robust quantification of contrast uptake rate in gadoxetic acid-enhanced MRI.

Josiah Simeth1,2, Yue Cao1,3,2.   

Abstract

PURPOSE: Gadoxetic acid uptake rate (k1 ) obtained from dynamic, contrast-enhanced (DCE) magnetic resonance imaging (MRI) is a promising measure of regional liver function. Clinical exams are typically poorly temporally characterized, as seen in a low temporal resolution (LTR) compared to high temporal resolution (HTR) experimental acquisitions. Meanwhile, clinical demands incentivize shortening these exams. This study develops a neural network-based approach to quantitation of k1 , for increased robustness over current models such as the linearized single-input, two-compartment (LSITC) model.
METHODS: Thirty Liver HTR DCE MRI exams were acquired in 22 patients with at least 16 min of postcontrast data sampled at least every 13 s. A simple neural network (NN) with four hidden layers was trained on voxel-wise LTR data to predict k1 . Low temporal resolution data were created by subsampling HTR data to contain six time points, replicating the characteristics of clinical LTR data. Both the total length and the placement of points in the training data were varied considerably to encourage robustness to variation. A generative adversarial network (GAN) was used to generate arterial and portal venous inputs for use in data augmentation based on the dual-input, two-compartment, pharmacokinetic model of gadoxetic acid in the liver. The performance of the NN was compared to direct application of LSITC on both LTR and HTR data. The error was assessed when subsampling lengths from 16 to 4 min, enabling assessment of robustness to acquisition length.
RESULTS: For acquisition lengths of 16 min NRMSE (Normalized Root-Mean-Squared Error) in k1 was 0.60, 1.77, and 1.21, for LSITC applied to HTR data, LSITC applied to LTR data, and GAN-augmented NN applied to LTR data, respectively. As the acquisition length was shortened, errors greatly increased for LSITC approaches by several folds. For acquisitions shorter than 12 min the GAN-augmented NN approach outperformed the LSITC approach to a statistically significant extent, even with HTR data.
CONCLUSIONS: The study indicates that data length is significant for LSITC analysis as applied to DCE data for standard temporal sampling, and that machine learning methods, such as the implemented NN, have potential for much greater resilience to shortened acquisition time than directly fitting to the LSITC model.
© 2020 American Association of Physicists in Medicine.

Entities:  

Keywords:  GAN; liver function; quantitative imaging

Mesh:

Substances:

Year:  2020        PMID: 31997391      PMCID: PMC7337040          DOI: 10.1002/mp.14055

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  26 in total

Review 1.  Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability.

Authors:  S P Sourbron; D L Buckley
Journal:  Phys Med Biol       Date:  2011-12-15       Impact factor: 3.609

2.  MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA.

Authors:  Akihiro Nishie; Yoshiki Asayama; Kousei Ishigami; Tsuyoshi Tajima; Daisuke Kakihara; Tomohiro Nakayama; Yukihisa Takayama; Daisuke Okamoto; Akinobu Taketomi; Ken Shirabe; Nobuhiro Fujita; Makoto Obara; Kengo Yoshimitsu; Hiroshi Honda
Journal:  J Magn Reson Imaging       Date:  2012-04-24       Impact factor: 4.813

Review 3.  Models and methods for analyzing DCE-MRI: a review.

Authors:  Fahmi Khalifa; Ahmed Soliman; Ayman El-Baz; Mohamed Abou El-Ghar; Tarek El-Diasty; Georgy Gimel'farb; Rosemary Ouseph; Amy C Dwyer
Journal:  Med Phys       Date:  2014-12       Impact factor: 4.071

Review 4.  Classic models for dynamic contrast-enhanced MRI.

Authors:  Steven P Sourbron; David L Buckley
Journal:  NMR Biomed       Date:  2013-05-15       Impact factor: 4.044

5.  Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.

Authors:  Steven Sourbron; Wieland H Sommer; Maximilian F Reiser; Christoph J Zech
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

6.  Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.

Authors:  N Verloh; M Haimerl; F Zeman; M Schlabeck; A Barreiros; M Loss; A G Schreyer; C Stroszczynski; C Fellner; P Wiggermann
Journal:  Eur Radiol       Date:  2014-02-16       Impact factor: 5.315

7.  A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion.

Authors:  Daniel Truhn; Christiane K Kuhl; Alexander Ciritsis; Alexandra Barabasch; Nils A Kraemer
Journal:  Eur Radiol       Date:  2018-06-15       Impact factor: 5.315

8.  Quantification of hepatic perfusion and hepatocyte function with dynamic gadoxetic acid-enhanced MRI in patients with chronic liver disease.

Authors:  Benjamin Leporq; Jean-Luc Daire; Catherine M Pastor; Pierre Deltenre; Christine Sempoux; Sabine Schmidt; Bernard E Van Beers
Journal:  Clin Sci (Lond)       Date:  2018-04-16       Impact factor: 6.124

9.  Monitoring of Total and Regional Liver Function after SIRT.

Authors:  Roelof J Bennink; Kasia P Cieslak; Otto M van Delden; Krijn P van Lienden; Heinz-Josef Klümpen; Peter L Jansen; Thomas M van Gulik
Journal:  Front Oncol       Date:  2014-06-16       Impact factor: 6.244

10.  Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma.

Authors:  Jiangfa Li; Xiaoqing Li; Jun Weng; Liping Lei; Jianhua Gong; Junyi Wang; Zhenghang Li; Longmiao Zhang; Songqing He
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

View more
  1 in total

1.  Estimation of pharmacokinetic parameters from DCE-MRI by extracting long and short time-dependent features using an LSTM network.

Authors:  Jiaren Zou; James M Balter; Yue Cao
Journal:  Med Phys       Date:  2020-06-03       Impact factor: 4.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.